Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-029512
Filing Date
2025-02-28
Accepted
2025-02-28 07:15:43
Documents
121
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K flgt-20241231.htm   iXBRL 10-K 5373531
2 EX-4.2 flgt-ex4_2.htm EX-4.2 47853
3 EX-19.1 flgt-ex19_1.htm EX-19.1 99518
4 EX-21.1 flgt-ex21_1.htm EX-21.1 10767
5 EX-23.1 flgt-ex23_1.htm EX-23.1 4060
6 EX-31.1 flgt-ex31_1.htm EX-31.1 16884
7 EX-31.2 flgt-ex31_2.htm EX-31.2 16928
8 EX-32.1 flgt-ex32_1.htm EX-32.1 17693
9 GRAPHIC img233114009_0.jpg GRAPHIC 8873
10 GRAPHIC img233114009_1.jpg GRAPHIC 9644
11 GRAPHIC img233114009_2.jpg GRAPHIC 9363
12 GRAPHIC img233114009_3.jpg GRAPHIC 20321
13 GRAPHIC img233114009_4.jpg GRAPHIC 382933
14 GRAPHIC img233114009_5.jpg GRAPHIC 383036
15 GRAPHIC img233114009_6.jpg GRAPHIC 350005
  Complete submission text file 0000950170-25-029512.txt   24814942

Data Files

Seq Description Document Type Size
16 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT flgt-20241231.xsd EX-101.SCH 2324995
124 EXTRACTED XBRL INSTANCE DOCUMENT flgt-20241231_htm.xml XML 5042568
Mailing Address 4399 SANTA ANITA AVE EL MONTE CA 91731
Business Address 4399 SANTA ANITA AVE EL MONTE CA 91731 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

EIN.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37894 | Film No.: 25682557
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)